WTW (WTW) Q2 2026 earnings review
R&B Rebound and AI Plan Propel Adjusted Margins, While GAAP Earnings Take a Hit
WTW delivered a robust operational rebound after a sluggish Q1. Organic revenue growth accelerated back to 5%, driven by a sharp 7% expansion in Risk & Broking (R&B). Adjusted operating margins expanded by a stable 100 bps to 19.5%, reflecting disciplined expense execution. However, GAAP Net Income collapsed 30% YoY. This optical divergence is entirely driven by a massive surge in transaction and integration costs related to the Newfront acquisition. Management's focal point was the newly announced 'Propel' plan—a sweeping $625M AI and automation investment targeting an ambitious ~30% enterprise adjusted operating margin by 2028. While execution risks remain, the capital return story is strong, bolstered by a fresh $1.5B share repurchase authorization.
🐂 Bull Case
Risk & Broking organic growth accelerated to 7% (from a weak 2% in Q1). Corporate Risk & Broking (CRB) proved that last quarter's new business timing issues were temporary, not structural.
The Propel AI Acceleration Plan targets $350M in net run-rate savings. This clearly charts a path to the ~30% adjusted operating margin goal by 2028, a massive step-up from 2025's 25.2% exit rate.
🐻 Bear Case
Transaction and integration expenses spiked to $61M in Q2 (up from $2M a year ago), crushing GAAP Net Income. Newfront integration will continue to weigh heavily on unadjusted earnings.
The Career business saw 0% organic growth (flat) due to continued Middle East conflicts, while Benefits Delivery & Outsourcing (BD&O) grew just 1%. Both heavily lag the enterprise average.
⚖️ Verdict: 🟢
Bullish. The core business rebounded perfectly from Q1's miss. The optical GAAP net income decline masks strong underlying 17% Adjusted EPS growth. The 'Propel' margin target and $1.5B buyback boost create a highly compelling multi-year capital return and efficiency story.
Key Themes
Propel AI Acceleration Plan Targets ~30% Margin
WTW unveiled 'Propel', a dedicated AI and automation plan aiming for ~30% adjusted operating margin by 2028 (up from 25.2% in FY25). This requires a $625M cash investment to achieve ~$400M in gross run-rate savings (~$350M net). Initiatives include scaling AI tools like 'Neuron' in R&B and deploying AI agents to automate high-volume workflows in HWC. This structural shift moves WTW from incremental cost-cutting to aggressive technological transformation.
Risk & Broking Re-accelerates
Following a highly scrutinized Q1 where R&B organic growth decelerated to 2%, the segment rebounded sharply to 7% organic growth in Q2. CRB growth was 7% and ICT growth came in at 6% (accelerating from Q1). This confirms management's prior assertion that Q1 weakness was driven by new business timing and a tough comp, rather than a structural loss of market share.
Career and BD&O Remain Laggards
While R&B and Health recovered, specific HWC sub-segments are dragging the blended average. Career organic growth was stable but flat (0%), still hampered by Middle East geopolitical headwinds and cautious discretionary spending. Benefits Delivery & Outsourcing (BD&O) only mustered 1% organic growth due to lower Individual Marketplace commissions. These segments require close monitoring as they offset the strong +8% growth in Health.
GAAP vs Non-GAAP Divergence Reversing Profit Narrative
There is a massive wedge between reported and adjusted figures this quarter. Adjusted Diluted EPS was $3.35 (+17%), but GAAP Diluted EPS collapsed 27% to $2.43. The culprit is a massive spike in transaction and integration expenses ($61M vs $2M in Q2'25), largely tied to integrating the Newfront acquisition. While investors typically look past integration costs, a $59M YoY spike creates significant near-term drag on actual cash profitability.
Other KPIs
A reversing trend that severely impacted GAAP Net Income. Costs exploded from $2M in Q2'25 to $61M in Q2'26. Management notes this is primarily driven by share-based compensation and transaction-related costs from the Newfront acquisition. This metric will remain elevated as the company executes its 'Propel' plan and integrates recent M&A.
Accelerating significantly from $217M in the prior year period. The $143M increase was primarily driven by operating margin expansion and evolving business mix, providing ample liquidity to fund the newly announced $1.5 billion increase to the share repurchase authorization.
Stable and expanding. Represents an 80 bps improvement YoY (from 20.8% in 25Q2). It proves that core operational leverage remains intact despite the optical drag from integration costs below the EBITDA line.
Guidance
Stable. The company reiterated its expectation for MSD growth across both HWC and R&B segments. Health remains the strongest sub-segment guided at High-Single Digits (HSD).
Stable. WTW continues to guide for 100 bps of annual expansion in R&B, alongside incremental expansion in HWC. This is the stepping stone toward the new 2028 'Propel' targets.
Accelerating margin profile. This is the most significant forward-looking metric provided. Achieving ~30% by 2028 implies roughly 480 bps of expansion from the 2025 exit rate of 25.2%. Segment targets are ~35% for HWC and ~30% for R&B.
Stable. After repurchasing $450M in Q2 and adding a $1.5B authorization, the company is easily on pace to exceed this floor.
Key Questions
Propel Cash Drag vs ROI
The Propel plan requires a massive $625M cash investment to achieve $350M in net run-rate savings. Over what specific timeline will this cash be deployed, and how quickly should investors expect to see the offsetting margin expansion materialize in the P&L?
Career Segment Turnaround
Career organic growth was flat (0%) this quarter. If Middle East geopolitical headwinds persist through 2026, what levers can you pull in North America and Europe to offset this and meet your Low-to-Mid Single Digit annual guidance for the segment?
Integration Cost Run-Rate
Transaction and integration costs spiked to $61M in Q2 due to Newfront. Is this the peak quarterly run-rate for these expenses, or should we expect similar or higher levels in H2 2026 as Newfront technology is rolled out across North America?
Software Sales Sustainability
Insurance Consulting and Technology (ICT) delivered a strong 6% organic growth rate driven by software sales. Given client caution around large, multi-year technology decisions noted in prior quarters, was this quarter's growth driven by timing of a few large deals, or a structural improvement in the consulting environment?